CME Masterclass

Everything you need to diagnose and treat BHRT and Thyroid disorders for men and women. The course includes didactic training for pellet and non-pellet hormones, as well as legal considerations, and consent forms, and everything you need to start practicing.

  • Videos, reference materials, consents, forms, guidebooks

  • Lifetime access to the materials

  • Industry expert trainers Dr. Angela DeRosa & Dr. Melissa Loseke

  • Exclusive: Live peer to peer community and knowledge base to review and ask questions from others in the course


Why CMEs?

Over the last few years since we started the Hormonal Health Institute, we have received countless requests for a CME option. It is with great excitement, that we are now able to offer the Master Class of Bio-identical and Thyroid Bundle with CME credit. We thank you for your dedication to the field of restorative and optimal medicine.


  • AMA PRA Category 1 Statement

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Foundation for Care Management (FCM) and Hormone Health Institute. The Foundation for Care Management is accredited by the ACCME to provide continuing medical education for physicians. FCM designates this educational activity for a maximum of 11.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in this activity. The ACCME defines an ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. CMEs must be claimed by 12/31/23

  • Nursing Statement

    Foundation for Care Management is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. CMEs must be claimed by 12/31/23

  • Pharmacy Statement

    The Foundation for Care Management is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Program # 0347-9999-21-011-H01-P Objectives appropriate for pharmacists. This activity is 11.5 Contact Hours Pharmacy Credit. *This CME is Knowledge Based (K). Initial release October 1, 2021. CMEs must be claimed by 12/31/23

Course Curriculum

  • 1


    • Welcome to the CME Masterclass: BHRT & Thyroid & Summary Dosing Reference Guide

    • Accreditation Statement & Disclosures

    • Summary of BHRT Dosing

    • How to properly assess BHRT patient cases

  • 2

    BHRT 101

    • Hormone Therapy 101 ( 31- minute lecture)

    • Hormones 101 Lecture Notes

    • Hormone Therapy 101 For Males ( 40-minute lecture)

    • Hormone Therapy 101: Male Patients Lecture Notes

    • Hormone Cascade Diagram

    • Reference: Menopause-Rating-Scale-MRS

    • AMS_English

    • ADAM Questionnaire

  • 3

    Proper Interpretation of BHRT Labs

    • Assessing Hormonal Labs ( 74-minute lecture)

    • Proper Interpretation of BHRT Labs: Male & Female Patients Lecture Notes

    • Reference: Optimal LAB Panels v3

    • Female Lab Exam

  • 4

    Hormone Decline & Staging in Female Patients

    • Staging Female Patients ( 46-minute lecture)

    • Hormone Decline & Staging in Female Patients Lecture Notes

    • Reference: Stages of Hormone Decline in Women with Pellet Dosing

  • 5

    Birth Control Options: The Good. The Bad. The Ugly.

    • Birth Control Options: The Good. The Bad. The Ugly. ( 32-minute video)

    • Birth Control Options: The Good. The Bad, The Ugly Lecture Notes

    • Reference: Oral Birth Control Pills

  • 6

    Pros and Cons of Different BHRT Treatment Options

    • Pros & Cons of Different HRT Options ( 38-minute lecture)

    • Pros and Cons of Different BHRT Treatment Options Lecture Notes

    • Reference: HRT Options Pros and Cons

  • 7

    Dosing Non-Pellet BHRT Treatment Options

    • Dosing Non-Pellet Options ( 74-minute lecture)

    • Dosing Non-Pellet BHRT Treatment Options Lecture Notes

    • Reference: Non-Pellet Dosing Options (Females)

  • 8

    Progesterone & Uterine Bleeding Protocols

    • Post Menopausal Progesterone and Break Through Bleeding Protocols (23-minute lecture)

    • Progesterone & Uterine Bleeding Protocols Lecture Notes

    • Reference: Progesterone and Bleeding Protocol

  • 9

    How to Manage Adverse Effects of BHRT

    • Management of Side Effects and Adverse Events ( 36-minute lecture)

    • How to Manage Adverse Effects of BHRT Lecture Notes

    • Management of Side Effects & Adverse Effects of HRT

  • 10

    How to Properly Dose Pellets and Pellet Case Studies

    • Pellet Dosing Protocols ( 54-minute lecture)

    • How to Properly Dose Pellets & Pellet Case Studies Lecture Notes

    • Reference: Female Pellet Dosing

    • Reference: Male Pellet Dosing

  • 11

    Pellet Insertion Technique Videos

    • Pellet Insertion Training for Female Patients ( 12-Minute Video Demonstration)

    • Pellet Insertion Video Male Patient ( 17-Minutes)

    • Pellet Insertion Training Manual

  • 12

    Thyroid Disorders

    • Thyroid Evaluation & Lab Interpretation ( 49-minute lecture)

    • Thyroid Evaluation and Lab Interpretation Notes

    • Thyroid Case Studies ( 36-minute lecture)

    • Thyroid Management & Treatment with Case Studies Notes

    • Reference: Hypothyroidism

  • 13

    How to Protect from Legal & Board Action

    • How to Protect from Legal & Board Action ( 31-minute video)

    • How to Protect Yourself from Legal & Board Action

    • Forms & Consents

    • ABN's

    • Female EMR Templates & Consent Forms

    • Flowsheets

    • Inventory Management

    • Male EMR Templates & Consent Forms

    • New Patient Paperwork

    • Post Pellet Insertion Patient Instructions

    • Questionnaires

    • Federation Guidelines

  • 14

    Bio Identical Hormone Therapy & Hormone Exam from Hormonal Health Institute

    • Bio-identical Hormone Therapy & Thyroid Evaluation & Treatment Examination

  • 15

    CME Accreditation Examination & Instructions for Claiming CME Credits

    • How to Claim CME Credit: Instructions

  • 16

    Reference Library

    • Destroying the Myth about Testosterone Replacement Prostate Cancer

    • Hormone Cascade (1)

    • Risk of Testosterone-Replacement Therapy

    • Death by T

    • DeRosaRebuttal to Pellet study June 2020

    • Federation-guidelines (1)

    • Glaser Dim 13 Reduced BCA incidence T T+ A (1)

    • How to properly assess BHRT patient cases

    • NAMS-2017-hormone-therapy-position-statement (1)

    • Myths about T1

    • Postmenopausal hormone therapy for cardiovascular health - the evolving data

    • Global Consensus Statement on Menopausal Hormone Therapy

    • Gender Bias in Medicine

    • Donovitz_Low_Complication_Rates_of_Testosterone_and_Estradiol_Implants_for_Androgen_and_Estrogen_Replacement_Therapy_in_Over_One_Million_Procedures

    • Peripheral thryoid conversion

    • FSH blocking agent development 2020 (1)

    • Impact of Micronized Progesterone on Breast Cancer

    • Testosterone and prostate

    • Subcutaneous Testosterone Anastrazole Therapy in Men


    • Testosterone Supplementation in Women

    • Testosterone in Women International Consensus

    • HRT geriatric thyroid A4m (1) (1)

    • Tesosterone implants in women Glaser

    • Testosterone Therapy and Cardiovascular Risk

    • Updated_Donovitz_European_Journal_of_Breast_Health_April_2021

    • Testosterone and the Female Voice

    • TSH_Proves_to_be_an_unreliable_test_for_Hypothyroidism

    • Thyroid-Hormone-Transport-into-Cellular-Tissue

    • Testosterone Implant Therapy in Women With and Without Breast Cancer

    • The Aging Male, 2018

    • What are we to believe

    • Thyroid and cellular transport

    • Hypothyroidism_low thyroid function_ Vasquez

    • Testosterone Implants in Women

    • How accurate is TSH testing (1)

    • Safety_and_efficacy_cBHT meta analysis: 2022 April The Journal of The North American Menopause Society

    • Breast cancer time for a change 2021: American Society of Clinical Oncology

Learning Objectives


  • 1. Summarize the indications and contraindications for the use of estradiol, progesterone, testosterone thyroid replacement

  • 2. Discuss clinical information for the use of estradiol, progesterone, testosterone and thyroid in patients diagnosed with hormonal deficiencies and explain how to clinical apply this knowledge in clinical practice

  • 3. Recall menopausal and andropausal basics and how to properly identify and assess hormone deficiency in men and women

  • 4. Review the evidence related to breast cancer, prostate cancer, cardiovascular disease as well as other clinical outcomes related to hormone replacement in men and women

  • 5. Describe how to manage the most common adverse events from hormonal therapies as well as the specifics related to pellet therapies

  • 6. Review the different mechanisms of action of each birth control option and how they impact hormonal balance in women

  • 7. Identify how to properly interpret hormonal labs in men and women as well as understand how to target “optimal” results post treatment

  • 8. Recall how to properly dose pellet and non-pellet therapies in men and women

  • 9. Describe how to properly dose thyroid replacements and which medications are best suited for each individual patient based on proper evaluation of their thyroid lab panels

  • 10. Identify the proper pellet insertion techniques for both men and women


HRT Expert, Author, Speaker, Entrepreneur

Angela DeRosa, DO, MBA, CPE

Dr. Angela DeRosa, DO, MBA, CPE, Medical Director for Belmar Pharma Solutions is a respected, internationally recognized authority on women’s hormonal health. As Medical Director, Dr. DeRosa will provide valuable clinical support to Belmar’s providers, including one-on-one discussions on complex patient cases and educational webinars on a variety of topics.

Dr. DeRosa’s appointment also gives Belmar the opportunity to align with the Hormonal Health Institute (HHI), a hormonal health consultancy founded by Dr. DeRosa in 2018. HHI offers physicians and clinical professionals medical and practice development training on bio-identical hormonal replacement therapy (BHRT), with an emphasis on pellet therapy. Through HHI, Belmar will offer its providers free monthly webinars and discounts on best-in-class training.

“Over the course of her career, Dr. DeRosa’s mission has been to change the face of women’s health and wellness by emphasizing the importance of balanced hormones as a foundation for optimal health. Belmar specializes in bio-identical hormone replacement therapy and other hormone-based wellness products, so naturally we’re excited to have Dr. DeRosa join our team,” Belmar CEO Dave Hill said. “Belmar and our providers will benefit immensely from both Dr. DeRosa’s vast expertise and experience as well as the resources of the Hormonal Health Institute.”

Dr. DeRosa has more than 25 years of experience in the medical field, both on the pharmaceutical side and in clinical practice. She served for several years as Senior Medical Director at Proctor & Gamble Pharmaceuticals, with a focus on the women’s health lines of osteoporosis and female sexual health. A board-certified internist with a specialty background in women’s health, Dr. DeRosa is the Founder and President of DeRosa Medical and DRM Integrative Health, where she treated over twenty thousand patients using advanced BHRT and optimization.

Dr. DeRosa is also an accomplished author, lecturer, and published researcher. After the publication of her first book, How Your Doctor Is Slowly Killing You: A Woman’s Health Survival Guide, in 2016, Dr. DeRosa received an avalanche of requests from physicians across the country wanting to learn more. The response was so overwhelming that Dr. DeRosa decided to launch the Hormonal Health Institute to share her knowledge with physicians and other medical healthcare providers in order to help change the face of women’s healthcare.

Dr. DeRosa received a Doctorate of Osteopathic Medicine from Midwestern University as well as a Master’s in Medical Management from Amherst College. She serves as Clinical Assistant Professor at Midwestern University, Arizona College of Osteopathic Medicine, and Clinical Assistant Professor of the Department of Internal Medicine at the University of Arizona College of Medicine-Phoenix. In addition to being Immediate Past President of the Arizona Osteopathic Medical Association, she is also a member of the International Menopause Society, the European Endocrine and Menopause Society, and the International Society of the Study of Women’s Sexual Health.

“As someone who’s long been impressed with Belmar’s dedication to patients’ health and its commitment to quality without compromise, I’m very excited to serve as its Medical Director,” Dr. DeRosa said. “While I’ve had a very diverse career path, one constant has been my commitment to the understanding of hormones and the role they play not only in the quality of life, but at preventing chronic illness. As Belmar Medical Director, I’m looking forward to sharing my knowledge and experience with Belmar’s providers.”

Family Medicine Physician

Melissa Loseke Ablett, DO

Dr. Melissa Loseke Ablett is a family medicine physician whose passion is innovative medicine. Dr. Loseke Ablett practiced primary care for 18 months before leaving and joining a clinic that specialized in treating chronic joint pain with Hyaluronic Acid injections, Platelet Rich Plasma (PRP), and Stem Cell therapies. With a constant desire to learn and for cutting-edge treatments for her patients, she began to practice at a nationwide hormone replacement organization specializing in pellet therapy for hormone replacement as well as aesthetics. During her tenure there, Dr. Loseke Ablett expanded her scope of certifications to include the Vampire Facelift, Vampire Breastlift, O shot, and Priapus Shot, as well as Low-Level Laser Therapy or Photobiomodulation to treat various injuries and chronic conditions. After four years of service, she then took a role as Chief Medical Officer for a national Testosterone Replacement Company and Medical Director of a partner Female Hormone Replacement Clinic. During these past several years, she was in the inaugural A4M Peptide Certification groups of providers. Dr. Loseke Ablett has been honored to continue the quest to offer patients comprehensive and innovative medical care to best meet their needs. Dr. Loseke Ablett constantly recommits herself to learning about the latest methods and treatments to help patients lead richer and healthier lives. Dr. Loseke Ablett has a passion for knowledge and educating, both patients and peers. One of her favorite sayings sums up the belief on the importance of not only balancing hormones but their vital role in overall health and well-being, “Our hormone levels don’t decline because we age...We age because our hormone levels decline.”